{"id":"https://openalex.org/W3010752008","doi":"https://doi.org/10.1080/10837450.2020.1744163","title":"Co-stabilization of pioglitazone HCL nanoparticles prepared by planetary ball milling: in-vitro and in-vivo evaluation","display_name":"Co-stabilization of pioglitazone HCL nanoparticles prepared by planetary ball milling: in-vitro and in-vivo evaluation","publication_year":2020,"publication_date":"2020-03-16","ids":{"openalex":"https://openalex.org/W3010752008","doi":"https://doi.org/10.1080/10837450.2020.1744163","mag":"3010752008","pmid":"https://pubmed.ncbi.nlm.nih.gov/32174213"},"language":"en","primary_location":{"id":"doi:10.1080/10837450.2020.1744163","doi":"https://doi.org/10.1080/10837450.2020.1744163","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10837450.2020.1744163","pdf_url":null,"source":{"id":"https://openalex.org/S80622011","display_name":"Pharmaceutical Development and Technology","issn_l":"1083-7450","issn":["1083-7450","1097-9867"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Development and Technology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053253712","display_name":"Doaa Hasan Alshora","orcid":"https://orcid.org/0000-0002-1276-2665","observed_orcids":["https://orcid.org/0000-0002-1276-2665"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Doaa H. Alshora","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038789257","display_name":"Shaikha M. Alsaif","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Shaikha Alsaif","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100633903","display_name":"Mohamed Abbas Ibrahim","orcid":"https://orcid.org/0000-0001-7535-5453","observed_orcids":["https://orcid.org/0000-0001-7535-5453"]},"institutions":[{"id":"https://openalex.org/I184834183","display_name":"Al-Azhar University","ror":"https://ror.org/05fnp1145","country_code":"EG","type":"education","lineage":["https://openalex.org/I184834183"]},{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["EG","SA"],"is_corresponding":false,"raw_author_name":"Mohamed A. Ibrahim","raw_affiliation_strings":["Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Al-Azhar University, Assiut, Egypt;","Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Al-Azhar University, Assiut, Egypt;","institution_ids":["https://openalex.org/I184834183"]},{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Essam Ezzeldin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]},{"id":"https://openalex.org/I4210136593","display_name":"National Organization for Drug Control and Research","ror":"https://ror.org/0407ex783","country_code":"EG","type":"facility","lineage":["https://openalex.org/I4210136593","https://openalex.org/I4210160667","https://openalex.org/I4405259620"]}],"countries":["EG","SA"],"is_corresponding":false,"raw_author_name":"Essam Ezzeldin","raw_affiliation_strings":["Department of Pharmaceutical Chemistry and Drug Bioavailability Laboratory, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;","Drug Bioavailability Center, National Organization for Drug Control and Research, (NODCAR), Cairo, Egypt;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry and Drug Bioavailability Laboratory, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;","institution_ids":["https://openalex.org/I28022161"]},{"raw_affiliation_string":"Drug Bioavailability Center, National Organization for Drug Control and Research, (NODCAR), Cairo, Egypt;","institution_ids":["https://openalex.org/I4210136593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058458565","display_name":"Osaid T. Al Meanazel","orcid":"https://orcid.org/0000-0003-2262-7966","observed_orcids":["https://orcid.org/0000-0003-2262-7966"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Osaid T. Almeanazel","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040422536","display_name":"Amal El Sayeh F. Abou El Ela","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]},{"id":"https://openalex.org/I91041137","display_name":"Assiut University","ror":"https://ror.org/01jaj8n65","country_code":"EG","type":"education","lineage":["https://openalex.org/I91041137"]}],"countries":["EG","SA"],"is_corresponding":false,"raw_author_name":"Amal El Sayeh Abou El Ela","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, Assiut University, Assiut, Egypt","Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, Assiut University, Assiut, Egypt","institution_ids":["https://openalex.org/I91041137"]},{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091135253","display_name":"Lubna Y. Ashri","orcid":"https://orcid.org/0000-0003-1718-913X","observed_orcids":["https://orcid.org/0000-0003-1718-913X"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Lubna Y. Ashri","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;","institution_ids":["https://openalex.org/I28022161"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5053253712"],"corresponding_institution_ids":["https://openalex.org/I28022161"],"apc_list":null,"apc_paid":null,"fwci":0.4892,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.50478266,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"25","issue":"7","first_page":"845","last_page":"854"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9580000042915344},{"id":"https://openalex.org/keywords/nanoparticles","display_name":"nanoparticles","score":0.8090000152587891},{"id":"https://openalex.org/keywords/planetary-ball-milling","display_name":"planetary ball milling","score":0.9350000023841858},{"id":"https://openalex.org/keywords/wet-milling","display_name":"wet milling","score":0.9110000133514404},{"id":"https://openalex.org/keywords/pluronic-f127","display_name":"Pluronic F127","score":0.9559999704360962},{"id":"https://openalex.org/keywords/sodium-deoxycholate","display_name":"sodium deoxycholate","score":1.0},{"id":"https://openalex.org/keywords/co-stabilization","display_name":"co-stabilization","score":0.8930000066757202},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.8510000109672546},{"id":"https://openalex.org/keywords/dissolution-enhancement","display_name":"dissolution enhancement","score":0.703000009059906},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.8130000233650208},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8730000257492065},{"id":"https://openalex.org/keywords/zeta-potential","display_name":"zeta potential","score":0.6230000257492065},{"id":"https://openalex.org/keywords/box-behnken-design","display_name":"Box-Behnken design","score":0.8140000104904175}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.7467826008796692},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.7216113805770874},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.6656016111373901},{"id":"https://openalex.org/C101335993","wikidata":"https://www.wikidata.org/wiki/Q408943","display_name":"Poloxamer","level":4,"score":0.6006336212158203},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.5872116684913635},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.5429950952529907},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.5276217460632324},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5072033405303955},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5010943412780762},{"id":"https://openalex.org/C169222746","wikidata":"https://www.wikidata.org/wiki/Q4116558","display_name":"Factorial experiment","level":2,"score":0.4952220022678375},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.4616277515888214},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.42673635482788086},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.4244460165500641},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.3863995671272278},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3483430743217468},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.347870409488678},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.2623342275619507},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.21234336495399475},{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.12179261445999146},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.11823320388793945},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.07644087076187134},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014961","descriptor_name":"X-Ray Diffraction","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/10837450.2020.1744163","doi":"https://doi.org/10.1080/10837450.2020.1744163","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10837450.2020.1744163","pdf_url":null,"source":{"id":"https://openalex.org/S80622011","display_name":"Pharmaceutical Development and Technology","issn_l":"1083-7450","issn":["1083-7450","1097-9867"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Development and Technology","raw_type":"journal-article"},{"id":"pmid:32174213","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32174213","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical development and technology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1526857981","https://openalex.org/W1576568858","https://openalex.org/W1982982125","https://openalex.org/W1999435898","https://openalex.org/W2016220756","https://openalex.org/W2043047859","https://openalex.org/W2052656589","https://openalex.org/W2064802984","https://openalex.org/W2094083143","https://openalex.org/W2159465632","https://openalex.org/W2267289794","https://openalex.org/W2341028373","https://openalex.org/W2341098675","https://openalex.org/W2400986352","https://openalex.org/W2498266468","https://openalex.org/W2513963902","https://openalex.org/W2597835381","https://openalex.org/W2754598189","https://openalex.org/W2781120803","https://openalex.org/W2788760360","https://openalex.org/W2797964318","https://openalex.org/W2817199556","https://openalex.org/W2884659974","https://openalex.org/W2890234943","https://openalex.org/W2900700412","https://openalex.org/W2921750297","https://openalex.org/W2948505517","https://openalex.org/W2953854656","https://openalex.org/W2956564433","https://openalex.org/W2988127286"],"related_works":["https://openalex.org/W2490617707","https://openalex.org/W3167352309","https://openalex.org/W7220575502","https://openalex.org/W7202124605","https://openalex.org/W4224229790","https://openalex.org/W3134105364","https://openalex.org/W2797260845","https://openalex.org/W4327748716","https://openalex.org/W3148335718","https://openalex.org/W4310068864"],"abstract_inverted_index":{"Pioglitazone":[0],"(PGZ)":[1],"is":[2,19],"an":[3,37],"oral":[4,43],"antidiabetic":[5],"agent":[6],"that":[7,114,158,194],"increases":[8],"cell":[9],"resistance":[10],"to":[11,60,141,157,193],"insulin,":[12],"thereby":[13],"decreasing":[14],"blood":[15],"glucose":[16],"levels.":[17],"PGZ":[18,70,135,176],"a":[20,58,80,107],"class":[21],"II":[22],"drug.":[23,69,198],"Because":[24],"of":[25,65,86,101,117,131,159,195],"its":[26,49,189],"pH-dependent":[27],"solubility,":[28],"it":[29],"precipitates":[30],"at":[31],"the":[32,62,75,87,115,123,127,139,160,184,196],"intestinal":[33],"pH,":[34],"resulting":[35],"in":[36,48,153,183],"erratic":[38],"and":[39,99,126,163,166],"incomplete":[40],"absorption":[41],"following":[42],"administration,":[44],"which":[45,187],"causes":[46],"fluctuations":[47],"plasma":[50],"concentration.":[51],"A":[52],"nanoparticle":[53,136,177],"drug":[54,190],"delivery":[55],"system":[56],"offers":[57],"solution":[59],"enhance":[61],"dissolution":[63,128,140,181],"rate":[64,182],"this":[66],"poorly":[67],"water-soluble":[68],"nanoparticles":[71],"were":[72,104,168],"formulated":[73],"by":[74],"wet":[76],"milling":[77,102],"technique":[78],"using":[79,106],"planetary":[81],"ball":[82],"mill.":[83],"The":[84,111,133,147],"effects":[85],"steric":[88],"stabilizer":[89,95],"(Pluronic":[90],"F-127,":[91],"PL":[92,118],"F-127),":[93],"electrostatic":[94],"(sodium":[96],"deoxycholate,":[97],"SDC),":[98],"number":[100],"cycles":[103],"optimized":[105,134],"Box-Behnken":[108],"factorial":[109],"design.":[110],"results":[112,149],"showed":[113,150],"ratio":[116],"F-127:":[119],"SDC":[120],"significantly":[121,169],"affected":[122],"zeta":[124],"potential":[125],"efficiency":[129],"(DE%)":[130],"PGZ.":[132],"formulation":[137,178],"enhanced":[138,180],"reach":[142],"100%":[143],"after":[144],"5":[145],"min.":[146],"in-vivo":[148],"significant":[151],"enhancement":[152],"Cmax":[154],"(1.3-fold)":[155],"compared":[156],"raw":[161],"powder,":[162],"both":[164],"AUC0\u201324":[165],"AUC0\u2013\u221e":[167],"(p":[170],"<":[171],"0.05)":[172],"enhanced.":[173],"In":[174],"conclusion,":[175],"had":[179],"alkaline":[185],"media,":[186],"improved":[188],"bioavailability":[191],"relative":[192],"untreated":[197]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-03-23T00:00:00"}